Chen Shangsi, Yoo James J, Wang Min
Department of Mechanical Engineering, Faculty of Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong.
Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
Mater Today Bio. 2025 Feb 18;31:101594. doi: 10.1016/j.mtbio.2025.101594. eCollection 2025 Apr.
Uterine injuries, particularly damages to endometrium, are usually associated with abnormal menstruation, recurrent miscarriage, pregnancy complications, and infertility. Tissue engineering using cell-based, biomolecule-based, or biomaterial and scaffold-based strategies has emerged as a novel and promising approach for uterine regeneration. Stem cells, biomolecules, and porous scaffolds used alone or, very often, used in combination as a more effective treatment means have shown great potential in promoting uterine regeneration. The reported preclinical studies have indicated that appropriate tissue engineering strategies could safely and effectively reconstruct not only endometrium but also partial or even the whole uterine structure. However, the progress in the uterine regeneration area is slow in comparison to that of regenerating many other body tissues and hence it still remains a great challenge to apply uterine tissue engineering for clinical applications. In this review, conventional treatments for uterine-related diseases are briefly reviewed and discussed first. Subsequently, tissue engineering strategies (cell-based, biomolecule-based, biomaterial and scaffold-based, or their combinations) for uterine repair in preclinical studies and clinical trials are presented and analyzed. Finally, the challenges and perspectives in uterine regeneration are pointed and discussed. Despite various limitations and obstacles, the tissue engineering approach is viable and holds high promise for uterine regeneration.
子宫损伤,尤其是子宫内膜损伤,通常与月经异常、复发性流产、妊娠并发症和不孕有关。利用基于细胞、基于生物分子或基于生物材料和支架的策略进行组织工程,已成为一种新颖且有前景的子宫再生方法。单独使用或经常联合使用的干细胞、生物分子和多孔支架作为一种更有效的治疗手段,在促进子宫再生方面已显示出巨大潜力。已报道的临床前研究表明,适当的组织工程策略不仅可以安全有效地重建子宫内膜,还可以重建部分甚至整个子宫结构。然而,与许多其他身体组织的再生相比,子宫再生领域的进展较为缓慢,因此将子宫组织工程应用于临床仍然是一个巨大的挑战。在这篇综述中,首先简要回顾和讨论了子宫相关疾病的传统治疗方法。随后,介绍并分析了临床前研究和临床试验中用于子宫修复的组织工程策略(基于细胞、基于生物分子、基于生物材料和支架或它们的组合)。最后,指出并讨论了子宫再生中的挑战和前景。尽管存在各种限制和障碍,但组织工程方法对于子宫再生是可行的,并且具有很高的前景。